claim
FMI

Patent details


Title (priority date) Treating cancer by modulating RNA helicases (24.9.2008)
Reference: 52691
Inventors: BENTIRES-ALJ & NAGAMINE
Description: The patent application is based on the finding that Rhau (DHX36) becomes essential in transformed cells.
Applications: Therapy and diagnostics
Status: Pending EP and US
Opportunity: Exclusive and non-exclusive license
Publications:
Contact: Dr. Nicolas Favre, tel: +41 61 697 8382, nicolas.favre@fmi.ch
PCT File: WO2010/034700
About this site2018 © FMI Basel Switzerland